Skip to Content

Join the 'Fusilev' group to help and get support from people like you.

Fusilev News

FDA Approves Fusilev for Use in Patients with Colorectal Cancer

Posted 2 May 2011 by Drugs.com

IRVINE, Calif.--(BUSINESS WIRE)--Apr 30, 2011 - Spectrum Pharmaceuticals a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, received approval from the U.S. Food and Drug Administration (FDA) on April 29, 2011, for the use of Fusilev (levoleucovorin) in combination with 5-fluorouracil in the palliative treatment of patients ...

Ask a Question

Further Information

Related Condition Support Groups

Methotrexate Overdosage, Colorectal Cancer, Methotrexate Rescue

Fusilev Patient Information at Drugs.com